Home›Stock Screener›Gland Pharma›Intrinsic Value

Gland Pharma Intrinsic Value

Gland Pharma intrinsic value. Gland Pharma (GLAND) median intrinsic value is ₹6049.73 from 10 valuation models (range ₹988–₹8232), vs current price ₹3292.90 — +83.7% upside (Trading Below Calculated Value), margin of safety 45.6%. For current market price and key ratios, visit Gland Pharma stock price NSE.

Market Price (CMP)
₹3292.90
Primary Intrinsic Value
₹1550.56
Market Cap
₹5598 Cr
+83.7% Upside
Median Value
₹6049.73
Value Range
₹988 - ₹8232
Assessment
Trading Below Calculated Value
Safety Margin
45.6%

GLAND Valuation Methods Summary — DCF, Graham Number & P/E

Gland Pharma intrinsic value across 10 models vs current price ₹3292.90 — upside/downside and value range per method. Browse GLAND income statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1550.56 ₹1240.45 - ₹1860.67 -52.9% EPS: ₹70.48, Sector P/E: 22x
Book Value Method asset ₹8232.25 ₹7409.03 - ₹9055.48 +150.0% Book Value/Share: ₹6092.94, P/B: 2.0x
Revenue Multiple Method revenue ₹6585.80 ₹5927.22 - ₹7244.38 +100.0% Revenue/Share: ₹4477.65, P/S: 2.0x
EBITDA Multiple Method earnings ₹6585.80 ₹5927.22 - ₹7244.38 +100.0% EBITDA: ₹2212.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹6049.73 ₹4839.78 - ₹7259.68 +83.7% CF Growth: 6.8%, Discount: 15%
PEG Ratio Method growth ₹987.87 ₹889.08 - ₹1086.66 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1088.92 ₹980.03 - ₹1197.81 -66.9% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹6585.80 ₹5927.22 - ₹7244.38 +100.0% ROE: 11.2%, P/E Multiple: 12x
Graham Defensive Method conservative ₹3108.41 ₹2797.57 - ₹3419.25 -5.6% EPS: ₹70.48, BVPS: ₹6092.94
Dividend Yield Method dividend ₹987.87 ₹889.08 - ₹1086.66 -70.0% DPS: ₹20.00, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

GLAND Intrinsic Value vs Market Price — All Valuation Models

Gland Pharma fair value range ₹988–₹8232 vs current market price ₹3292.90 across 10 valuation models. Analyse GLAND shareholder distribution to track promoter, FII and institutional holdings.

GLAND Intrinsic Value Analysis — Undervalued or Overvalued?

Gland Pharma median intrinsic value ₹6049.73, current price ₹3292.90 — Trading Below Calculated Value by 83.7%, margin of safety 45.6%.

What is the intrinsic value of GLAND?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Gland Pharma (GLAND) is ₹6049.73 (median value). With the current market price of ₹3292.90, this represents a +83.7% variance from our estimated fair value.

The valuation range spans from ₹987.87 to ₹8232.25, indicating ₹987.87 - ₹8232.25.

Is GLAND undervalued or overvalued?

Based on our multi-method analysis, Gland Pharma (GLAND) appears to be trading below calculated value by approximately 83.7%.

GLAND Financial Health — Key Ratios vs Industry Benchmarks

Gland Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 11.2% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 26.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.61x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

GLAND Cash Flow Quality — Operating & Free Cash Flow

Gland Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹1,031 Cr ₹1,031 Cr Positive Free Cash Flow 8/10
March 2025 ₹915 Cr ₹915 Cr Positive Free Cash Flow 8/10
March 2024 ₹997 Cr ₹123 Cr Positive Free Cash Flow 7/10
March 2023 ₹364 Cr ₹364 Cr Positive Free Cash Flow 8/10
March 2022 ₹791 Cr ₹292 Cr Positive Free Cash Flow 7/10